Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is looking at a drug called rucaparib to treat triple negative breast cancer. It is also open to people with breast cancer caused by a fault in the BRCA 1 gene or BRCA 2 gene.
If breast cancer doesn’t have receptors for the hormones oestrogen or progesterone, or for the protein HER2, it is called triple negative breast cancer. This trial is supported by Cancer Research UK.
Recruitment start: 20 July 2015
Recruitment end: 1 December 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Nicholas Turner
Cancer Research UK
Clovis Oncology Inc
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
NIHR Clinical Research Network: Cancer
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK number CRUK/12/034.
Last reviewed: 11 December 2017
CRUK internal database number: 10083
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
